Literature DB >> 15852322

Pharmacologic treatment of anorexia nervosa: where do we go from here?

Evelyn Attia1, Laura Schroeder.   

Abstract

Anorexia nervosa (AN) is a serious mental disorder, characterized by severely low weight and cognitive distortions about body shape and weight. AN is generally associated with a range of psychological symptoms, including depression, anxiety, obsessions, and rituals. The current study summarized findings from randomized controlled trials (RCT) using pharmacologic treatments in patients with AN. We conducted a review of literature using Medline. Several classes of pharmacologic agents have been studied in small samples of patients with acute AN without finding clear benefit to eating, weight, body shape concerns, or associated psychopathology. Studies have been limited by small sample sizes, as well as by research design with most studies adding medication to comprehensive hospital-based treatment programs. Future directions for pharmacologic treatment research in AN should include outpatient trials, rigorous study of atypical antipsychotic medication, and assessment of medication effect for relapse prevention in weight-restored patients. 2005 by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852322     DOI: 10.1002/eat.20133

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  9 in total

Review 1.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

2.  Psychotropic usage by patients presenting to an academic eating disorders program.

Authors:  Karuna Mizusaki; Daniel Gih; Christina LaRosa; Rebekah Richmond; Renee D Rienecke
Journal:  Eat Weight Disord       Date:  2018-06-07       Impact factor: 4.652

Review 3.  Animal models of eating disorders.

Authors:  S F Kim
Journal:  Neuroscience       Date:  2012-03-21       Impact factor: 3.590

Review 4.  Serotonin: imaging findings in eating disorders.

Authors:  Ursula F Bailer; Walter H Kaye
Journal:  Curr Top Behav Neurosci       Date:  2011

5.  Mirtazapine in the treatment of adolescent anorexia nervosa. Case-control study.

Authors:  Michal Hrdlicka; Irena Beranova; Renata Zamecnikova; Tomas Urbanek
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04       Impact factor: 4.785

6.  Altered insula activation during pain anticipation in individuals recovered from anorexia nervosa: evidence of interoceptive dysregulation.

Authors:  Irina A Strigo; Scott C Matthews; Alan N Simmons; Tyson Oberndorfer; Megan Klabunde; Lindsay E Reinhardt; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-07-27       Impact factor: 4.861

7.  Eating disorders: National Institute of Mental Health's perspective.

Authors:  Mark Chavez; Thomas R Insel
Journal:  Am Psychol       Date:  2007-04

8.  Eating Disorders on College Campuses in the United States: Current Insight on Screening, Prevention, and Treatment.

Authors:  Anne C Grammer; Ellen E Fitzsimmons-Craft; Olivia Laing; Bianca De Pietro; Denise E Wilfley
Journal:  Curr Psychopharmacol       Date:  2020

9.  Meta analysis on the efficacy of pharmacotherapy versus placebo on anorexia nervosa.

Authors:  Jasmijn de Vos; Laura Houtzager; Georgia Katsaragaki; Elske van de Berg; Pim Cuijpers; Jack Dekker
Journal:  J Eat Disord       Date:  2014-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.